Presentation of Intracerebral Haemorrhage in a Community
JNNP 77:340-344, Zahuranec,D.B.,et al, 2006
Epilepsy in Children
Lancet 367:499-524, Guerrini,R., 2006
The First Seizure and Its Management in Adults and Children
BMJ 332:339-342, Pohlmann-Eden,B.,et al, 2006
Shotgun Pellet Embolization to the Posterior Cerebral Circulation
AJNR 27:261-263, deCosta,L.B.,et al, 2006
Vasculopathic Changes in the Cerebral Arterial System with Neurobrucellosis
AJNR 27:384-386, Adaletli,I.,et al, 2006
Standardized MR Imaging Protocol for Multiple Sclerosis:Consortium of MS Centers Consensus Guidelines
AJNR 27:455-461, Simon,J.H.,et al, 2006
Remote Cerebellar Hemorrhage
AJNR 27:387-390, Amini,A.,et al, 2006
CT and MR Imaging Findings in Methanol Intoxication
AJNR 27:452-454, Blanco,M.,et al, 2006
Diffusion MR Imaging in a Case of Acute Ischemic Optic Neuropathy
AJNR 27:255-257, Al-Shafai,L.S.&Mikulis,D.J., 2006
Hyperostosis Frontalis Interna
Arch Neurol 63:291, Waclawik,A.J., 2006
The "Eye-of-the-Tiger" Sign is Not Pathognomonic of the PANK2 Mutation
Arch Neurol 63:292-293, Kumar,N.,et al, 2006
Safety and Tolerability of Interferon Beta-1b in Pediatric Multiple Sclerosis
Neurol 66:472-476, Banwell,B.,et al, 2006
Alexander Disease, Ventricular Garlands and Abnormalities of the Medulla and Spinal Cord
Neurol 66:494-498,468, van der Knaap,M.S.,et al, 2006
Left Insular Stroke is Associated with Adverse Cardiac Outcome
Neurol 66:477-483, Laowattana,S.,et al, 2006
Linezolid-Associated Toxic Optic Neuropathy
Neurol 66:595-598, Rucker,J.C.,et al, 2006
Internal and Cortical Border-Zone Infarction, Clinical and Diffusion-Weighted Imaging Features
Stroke 37:841-846, Yong,S.W.,et al, 2006
Role of CT Angiography in Thrombolysis Decision-Making for Patients with Presumed Seizure at Stroke Onset
Stroke 37:915-917, Sylaja,P.N.,et al, 2006
Reversible Posterior Leukoencephalopathy Syndrome and Bevacizumab
NEJM 354:980-982, Ozcan,C.,et al, 2006
Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis
NEJM 354:911-923,965, Rudick,R.A.,et al, 2006
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 354:899-910,965, Polman,C.H.,et al, 2006
Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy
NEJM 354:924-933,965, Yousry,T.A.,et al, 2006
IM Interferon B-1a Delays Definite Multiple Sclerosis 5 Years After a First Demyelinating Event
Neurol 66:678-684, CHAMPIONS Study Group, 2006
Gray and White Matter Brain Atrophy and Neuropsychological Impairment in Multiple Sclerosis
Neurol 66:685-692, Sanfilipo,M.P.,et al, 2006
Bilateral Basal Gaglionic Hemorrhage
Arch Neurol 63:464, Verma,A., 2006
Triplopia, Thirteen Patients From a Neurology Inpatient Service
Arch Neurol 63:388-389, Keane,J.R., 2006
Brain Abnormalities in Neuromyelitis Optica
Arch Neurol 63:390-396, Pittock,S.J.,et al, 2006
Clinicopath Conf, Diffuse Large B-Cell Lymphoma, EBV-Positive, with Immunosuppression
NEJM 354:1178-1184, Case 8-2006, 2006
Diagnosis and Treatment of Multiple Sclerosis
BMJ 332:525-527, Murray,T.J., 2006
Time to Admission in Acute Ischemic Stroke and Transient Ischemic Attack
Stroke 37:963-966, Agyeman,O.,et al, 2006
Extent of Early Ischemic Changes on Computed Tomgraphy (CT) Before Thrombolysis
Stroke 37:973-978, Dzialowski,I.,et al, 2006
MRI of Clot in Cerebral Venous Thrombosis
Stroke 37:991-995, Idbaih,A.,et al, 2006
Homonymous Hemianopias
Neurol 66:906-910, Zhang,X.,et al, 2006
Frequency of Spinal Arteriovenous Malformations in Patients with Unexplained Myelopathy
Neurol 66:928-931, Strom,R.G.,et al, 2006
Central Respiratory Dysfunction Following Vertebral artery Dissection
Neurol 66:944, Lanczik,O.,et al, 2006
Improved Detection of Metastatic Melanoma by T2*-Weighted Imaging
AJNR 27:605-608, Gaviani,P.,et al, 2006
The Solitary Enhancing Cerebral Lesion: Can FLAIR Aid the Differentiation Between Glioma and Metastasis
AJNR 27:609-611, Tang,Y.M.,et al, 2006
Combinations of the Presence or Absence of Cerebral Microbleeds and Advanced White Matter Hyperintensity as Predictors of Subsequent Stroke Types
AJNR 27:830-835, Naka,H.,et al, 2006
Hanging Leg Syndrome: Combined Bilateral Femoral and Sciatic Neuropathies
Neurol 66:1124-1125, Scherer,K.,et al, 2006
Nonconvulsive Status Epilepticus in Metastatic CNS Disease
Neurol 66:1261-1263, Blitshteyn,S. &Jaeckle,K.A., 2006
Natalizumab: Immune Effects and Implications for Therapy
Ann Neurol 59:731-732, Hauser,S.L. &Weiner, H.L., 2006
International Study on Low-Grade Primary Central Nervous System Lymphoma
Ann Neurol 59:755-762, Jahnke,K.,et al, 2006
Antiplatelets, ACE Inhibitors, and Statins Combination Reduces Stroke Severity and Tissue At Risk
Neurol 66:1153-1158, Kumar,S.,et al, 2006
Is IV Tissue Plasminogen Activator Beneficial in Patients With Hyperdense Artery Sign?
Neurol 66:1171-1174, Qureshi,A.I.,et al, 2006
MR Diffusion-Weighted Imaging and Outcome Prediction After Ischemic Stroke
Neurol 66:1159-1163, Hand,P.J.,et al, 2006
MATILDE Regimen Followed by Radiotherapy is an Active Strategy Against Primary CNS Lymphomas
Neurol 66:1435-1438, Ferreri,A.J.M.,et al, 2006
MRI T2 Lesion Burden in Multiple Sclerosis. A Plateauing Relationship with Clinical Disability.
Neurol 66:1384-1389, Li,D.K.B.,et al, 2006
Neuropathy Progressing to Myeloneuropathy 20 Years After Partial Gastrectomy
Neurol 66:1451, Everett,C.M.,et al, 2006
Multiple Sclerosis: New Insights and Trends
AJNR 27:954-957, Inglese,M., 2006
CT and MR Imaging of Neuroaxonal Leukodystrophy Presenting as Early-Onset Frontal Dementia
AJNR 27:1037-1039, Mascalchi,M.,et al, 2006
Neuropathology of the Neuroradiologist: Rosenthal Fibers
AJNR 27:958-961, Wippold,F., II,et al, 2006